College of Pharmacy
Schmittgen Lab
Led by Thomas D Schmittgen · Pharmaceutics
What we study
The lab studies microRNAs and their role in cancer, using them as potential therapeutic or diagnostic tools. They also develop exosomes/microvesicles for targeted drug delivery in cancer treatment.
What working here is like
- Wet lab
- Project
- 1
- Papers
- 5
Current projects
Exosomes/microvesicles as targeted drug delivery systems
Developing exosomes/microvesicles for targeted drug delivery in cancer treatment.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Campylobacter jejuni infection impacts host-derived miRNAs targeting bacterial and host genes
2026 · Microbiology Spectrum
Found that Campylobacter jejuni infection changes host-derived microRNAs in mice.
- Dimensional Priming Reprograms Adipose-Derived Stromal Cells to Promote Pancreatic Cancer Progression
2026 · Cancers
Shows how 3D culture changes adipose-derived stromal cells to promote pancreatic cancer growth.
Show 3 more papersShow fewer
- Renin–angiotensin–aldosterone system inhibitors and risk of pancreatic cancer in older adults: A target trial emulation
2026 · International Journal of Cancer
Used US Medicare data to compare RAAS inhibitors and calcium channel blockers for preventing pancreatic cancer.
- RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer
2025 · Nature Cell Biology
- Transcriptomic Analyses of Normal Human Pancreata Reveal the Presence of Cancer Subtypes that Correlate with Acinar Ductal Metaplasia and Donor Ancestry
2025 · Cancer Research Communications
Identified two molecular subtypes in normal human pancreatic acinar cells.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Thomas D Schmittgen hasn't set up this page yet. Their UF Scholars profile lists their publications.